老年营养风险指数预测IPF抗纤维化治疗耐受性与死亡风险
这项回顾性多队列研究纳入301例接受抗纤维化治疗的特发性肺纤维化(IPF)患者,用老年营养风险指数(GNRI)评估营养状态。37.5%患者存在营养不良相关风险(GNRI<98),该风险与抗纤维化治疗停药(尤其胃肠道原因)及更短生存相关,且为独立预后指标。
要点
- GNRI<98提示营养不良相关风险,与抗纤维化治疗停药风险升高相关。
- 营养不良相关风险者中位生存25.9个月,低于无风险者的41.1个月。
- 营养状态评估可为IPF患者管理提供重要信息。
核心结论
- 营养状态对IPF患者的治疗和结局有显著影响,营养不良相关风险是抗纤维化治疗停药和死亡的独立预后指标。
研究设计与样本
- 回顾性多队列研究,共评估301例接受抗纤维化治疗的IPF患者(Hamamatsu队列n=151;Seirei队列n=150)。
- 营养状态采用老年营养风险指数(GNRI)评估,GNRI基于体重指数和血清白蛋白计算。
主要发现
- 301例患者中113例(37.5%)存在营养不良相关风险(GNRI<98)。
- 营养不良相关风险者年龄更大、急性加重更多、肺功能更差。
- 营养不良相关风险与抗纤维化治疗停药发生率更高相关,尤其因胃肠道不适。
- 营养不良相关风险(GNRI<98)者中位生存25.9个月,无该风险者为41.1个月(p<0.001)。
- 多因素分析显示营养不良相关风险是抗纤维化治疗停药和死亡的预后指标,独立于年龄、性别、用力肺活量或性别-年龄-生理指数。
关键数值与推荐
- 营养不良相关风险判定阈值:GNRI<98。
- 中位生存:GNRI<98组25.9个月 vs 无风险组41.1个月,p<0.001。
临床怎么用
- 对接受抗纤维化治疗的IPF患者可评估GNRI等营养状态指标,识别停药与死亡高风险人群并加强管理。
局限性
- 为回顾性多队列研究,原文摘要未报告更多局限性信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Idiopathic pulmonary fibrosis (IPF) is characterized by progressive lung fibrosis of unknown aetiology. Epidemiological studies have suggested that IPF progression may negatively affect nutritional status. Weight loss during antifibrotic therapy is also frequently encountered. The association of nutritional status and outcome has not been fully evaluated in IPF patients. METHODS: This retrospective multicohort study assessed nutritional status of 301 IPF patients receiving antifibrotic therapy (Hamamatsu cohort, n = 151; Seirei cohort, n = 150). Nutritional status was evaluated using the Geriatric Nutritional Risk Index (GNRI). The GNRI was calculated based on body mass index and serum albumin. The relationship between nutritional status and tolerability of antifibrotic therapy as well as mortality was explored. RESULTS: Of 301 patients, 113 (37.5%) had malnutrition-related risk (GNRI < 98). Patients with malnutrition-related risk were older, had increased exacerbations and worse pulmonary function than those without a GNRI status <98. Malnutrition-related risk was associated with a higher incidence of discontinuation of antifibrotic therapy, particulary due to gastrointestinal disturbances. IPF patients with malnutrition-related risk (GNRI < 98) had shorter survival than those without such risk (median survival: 25.9 vs. 41.1 months, p < 0.001). In multivariate analysis, malnutrition-related risk was a prognostic indicator of antifibrotic therapy discontinuation and mortality, independent of age, sex, forced vital capacity, or gender-age-physiology index. CONCLUSION: Nutritional status has significant effects on the treatment and outcome in patients with IPF. Assessment of nutritional status may provide important information for managing patients with IPF.
引用
- Mochizuka Y, Suzuki Y, Kono M, et al. Geriatric Nutritional Risk Index is a predictor of tolerability of antifibrotic therapy and mortality risk in patients with idiopathic pulmonary fibrosis. Respirology. 2023. PMID: 37221050. doi:10.1111/resp.14523
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。